Karyopharm announces xpovio® (selinexor) clinical data to be presented at the american society of hematology 2020 annual meeting

Newton, mass., nov. 4, 2020 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq: kpti), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that twenty-one abstracts have been selected for virtual presentation, including two oral presentations, at...
KPTI Ratings Summary
KPTI Quant Ranking